[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
INDICES> Grey syndrome with very high chloramphenicol plasma levels (2)
- From: Beatriz Ortiz-Christiansen <Bchristnsn@aol.com>
- Date: Sun, 27 Feb 2000 09:43:56 -0500 (EST)
INDICES> Grey syndrome with very high chloramphenicol plasma levels (2)
-----------------------------------------------------------------------
>We would like to know the mechanism by which high plasma level of
>chloramphenicol causes Grey syndrome, a potentially fatal condition.
In the newborn there are a number of liver enzymes which are not fully able
to metabolize certain drugs. In the case of chloramphenicol, the absence or
deficiency of glucoronyl transferase activity in the newborn will delay the
metabolism of the drug to the inactive form. The result will be an elevated
chloramphenicol level which can cause cardiovascular collapse and death -
Gray baby syndrome.
Beatriz Ortiz-Christiansen, BS Pharm., RPh., MHS
CORTSEN Consulting Group, Inc.
e-mail: bchristnsn@aol.com
PS: For more information I have copied below a citation and abstract from
Medline:
TITLE: Chloramphenicol toxicity in neonates: its incidence and prevention.
AUTHORS: Mulhall A; de Louvois J; Hurley R SOURCE: Br Med J (Clin Res Ed)
1983 Nov 12;287(6403):1424-7 CITATION IDS: PMID: 6416440 UI: 84054121
ABSTRACT: The incidence of dose related chloramphenicol toxicity was
determined in 64 neonates from 12 hospitals. Ten of the 64 exhibited symptoms
attributed clinically to chloramphenicol toxicity. Nine received the dose
prescribed and one an overdose. Symptoms of the grey baby syndrome were
observed in five of the 10 babies; four babies suffered reversible
haematological reactions; and one baby was described as very grey. Peak serum
chloramphenicol concentrations in these 10 babies ranged from 28 to 180 mg/l
and trough concentrations from 19 to 47 mg/l. Serum chloramphenicol
concentrations above the therapeutic range (15-25 mg/l) were observed in a
further 27 neonates (two had received a 10-fold overdose), none of whom
showed signs of toxicity. Serious toxicity was associated with either
prescription of dosages greater than that recommended or overdosage of
chloramphenicol. High concentrations in young neonates may be avoided by
prescribing and giving the recommended dose and then careful monitoring;
concentrations should be maintained between 15 and 25 mg/l. No babies with
concentrations within this range showed clinical signs of toxicity.
[thanks, Beatriz! WB]
--
Send mail for the `INDICES' conference to `indices@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-indices@usa.healthnet.org'.
|